CVR: 40837590
Previous names: Ebumab Hemophilia ApS
Not available
Hemab Therapeutics Holdings, Inc.
CVR · view ownership and management
Owner registered: Hemab Therapeutics Holdings, Inc.
CVR · 30/03/2026
View the full event history
Hemab ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Ebumab Hemophilia ApS. The management consists of Benny Sørensen and Mads Nikolaj Behrndt-Eriksen. The company is owned by Hemab Therapeutics Holdings, Inc.. Equity in the 2025 report amounted to USD 196,000.
Selskabets formål er at drive virksomhed indenfor forskning, udvikling og markedsføring af produkter til brug for diagnosticering, behandling og/eller forebyggelse af hæmatologiske sygdomme med risiko for øget blødning eller udvikling af blodpropper.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | - | - | - | 196 t. USD | 54 | |
| 202401/01/2024 – 31/12/2024 | - | - | - | 104 t. USD | 36 | |
| 202301/01/2023 – 31/12/2023 | - | -22.8 mio. USD | 139.5 mio. USD | 136.2 mio. USD | 21 | |
| 202201/01/2022 – 31/12/2022 | - | -156.4 mio. | 32.9 mio. | 6.1 mio. | 10 | |
| 202101/01/2021 – 31/12/2021 | - | -35.2 mio. | 78.7 mio. | 68 mio. | 3 |
Compared to 128 companies in Fremstilling af farmaceutiske præparater
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorHemab ApS was founded on 27 September 2019.
Hemab ApS is registered under the industry Fremstilling af farmaceutiske præparater (industry code 212000).
Hemab ApS is owned by Hemab Therapeutics Holdings, Inc..
The management of Hemab ApS consists of Benny Sørensen and Mads Nikolaj Behrndt-Eriksen.
Hemab ApS is located at Nordre Fasanvej 215, 2000 Frederiksberg.
The CVR number of Hemab ApS is 40837590.
Claim this page to add your logo and social links. Free to get started.
Hemab ApS has published its annual report for 2025.
As of May 8, 2026, Laura Anne Tadvalkar has left the board of directors of Hemab ApS.
As of April 10, 2026, Jørgen Søberg Petersen has left the board of directors of Hemab ApS.
As of April 10, 2026, Daniel Becker has left the board of directors of Hemab ApS.
As of April 10, 2026, Uya Chuluunbaatar has left the board of directors of Hemab ApS.
As of April 10, 2026, Joseph Anderson has left the board of directors of Hemab ApS.
As of March 30, 2026, is registered as an owner of Hemab ApS with an ownership share of 100%.
As of October 23, 2025, Joseph Anderson has joined the board of directors of Hemab ApS.
As of October 23, 2025, Mårten Steen has left the board of directors of Hemab ApS.
Hemab ApS has published its annual report for 2024.
Hemab ApS has published its annual report for 2023. The net result was DKK -22,783,000.
As of January 16, 2024, Akshay Krishnadas Vaishnaw has joined the board of directors of Hemab ApS.
Hemab ApS has published its annual report for 2022. The net result was DKK -156,407,000.
As of March 1, 2023, Johan Henrik Faber has stepped down as director of Hemab ApS.
As of February 15, 2023, Benny Sørensen has joined the board of directors of Hemab ApS.
As of February 15, 2023, Daniel Becker has joined the board of directors of Hemab ApS.
As of February 15, 2023, Uya Chuluunbaatar has joined the board of directors of Hemab ApS.
As of February 15, 2023, Thomas Dal Stenfeldt Batchelor has left the board of directors of Hemab ApS.
Hemab ApS has published its annual report for 2021. The net result was DKK -35,163,000.
As of January 10, 2022, Jørgen Søberg Petersen has joined the board of directors of Hemab ApS.
As of January 10, 2022, Linda Catharina Bain has joined the board of directors of Hemab ApS.
As of January 10, 2022, John Michael Maraganore has joined the board of directors of Hemab ApS.
As of January 10, 2022, Benny Sørensen is registered as adm. dir. of Hemab ApS.
As of January 9, 2022, Jørgen Søberg Petersen has left the board of directors of Hemab ApS.
As of December 16, 2021, EY Godkendt Revisionspartnerselskab has been appointed auditor of Hemab ApS.
As of December 16, 2021, Slotsgade Revision ApS has stepped down as auditor of Hemab ApS.
As of September 1, 2021, Mads Nikolaj Behrndt-Eriksen is registered as director of Hemab ApS.
As of July 22, 2021, Thomas Dal Stenfeldt Batchelor has joined the board of directors of Hemab ApS.
As of July 22, 2021, Mårten Steen has joined the board of directors of Hemab ApS.
As of July 22, 2021, Laura Anne Tadvalkar has joined the board of directors of Hemab ApS.
As of July 22, 2021, Benny Sørensen has left the board of directors of Hemab ApS.
As of July 22, 2021, Johan Henrik Faber has left the board of directors of Hemab ApS.
As of July 22, 2021, Camilla Petrycer Hansen has left the board of directors of Hemab ApS.
Hemab ApS has published its interim report for the period September 27, 2019 – December 31, 2020.
As of November 20, 2020, Benny Sørensen has joined the board of directors of Hemab ApS.
As of November 20, 2020, Camilla Petrycer Hansen has joined the board of directors of Hemab ApS.
As of November 20, 2020, Jørgen Søberg Petersen has joined the board of directors of Hemab ApS.
As of November 20, 2020, Hans Heugh Wandall has left the board of directors of Hemab ApS.
As of November 20, 2020, Søren Erik Bjørn has left the board of directors of Hemab ApS.
As of November 20, 2020, Thomas Dal Stenfeldt Batchelor has left the board of directors of Hemab ApS.
As of July 15, 2020, Slotsgade Revision ApS has been appointed auditor of Hemab ApS.
As of July 15, 2020, KAPPELSKOV REVISION. GODKENDT REVISIONSAKTIESELSKAB has stepped down as auditor of Hemab ApS.
As of June 22, 2020, Hans Heugh Wandall has joined the board of directors of Hemab ApS.
As of June 22, 2020, Søren Erik Bjørn has joined the board of directors of Hemab ApS.
As of June 22, 2020, Kim Stengaard Holmsted has left the board of directors of Hemab ApS.
On June 22, 2020, the company changed its name from Ebumab Hemophilia ApS to Hemab ApS.
As of June 21, 2020, Hans Heugh Wandall has left the board of directors of Hemab ApS.
As of September 27, 2019, KAPPELSKOV REVISION. GODKENDT REVISIONSAKTIESELSKAB has been appointed auditor of Hemab ApS.
As of September 27, 2019, Hans Heugh Wandall has joined the board of directors of Hemab ApS.
As of September 27, 2019, Johan Henrik Faber has joined the board of directors of Hemab ApS.
As of September 27, 2019, Kim Stengaard Holmsted has joined the board of directors of Hemab ApS.
As of September 27, 2019, Thomas Dal Stenfeldt Batchelor has joined the board of directors of Hemab ApS.
As of September 27, 2019, Johan Henrik Faber is registered as director of Hemab ApS.
Hemab ApS was founded on September 27, 2019.
Companies in the same industry and area
CVR 38402056
CVR 39859173
CVR 39880377
CVR 42057428
CVR 43432583
